The average cost has increased 58% since analysts at the Seattle-based actuarial firm gathered similar data in 2011.
U.S. gross domestic product per resident increased just 22% over that same period. Overall per-capita health expenditures increased about 25%, according to government national health expenditure estimates.
The Milliman analysts have published data on kidney transplants and other types of tissue and organ transplants in its latest transplant report, to help health insurers, health plans, care providers, patients, government officials and others understand transplant finances.
The Milliman transplant cost totals include the estimated cost of pre-transplant care, tissue or organ procurement, hospital transplant services, physician transplant services, 180 days of post-transplant care, and the related prescription drugs.
The cost figures have obvious relevance to agents who sell products such as major medical insurance and critical care insurance.
The figures may also be of interest to financial advisors who help high-net-worth clients set aside enough of their own cash to self-insure against catastrophic health care costs.
Eyes v. Livers
The increases in transplant costs that have occurred since 2011 vary widely from procedure to procedure.
For cornea transplants, for example, costs have increased just 24% since 2011, to $30,200.